GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Short Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Short Term Provisions | ₹117 Cr | ₹125 Cr | ₹111 Cr | ₹32 Cr | ₹43 Cr |
What is the latest Short Term Provisions ratio of GLAND PHARMA ?
| Year | Short Term Provisions |
|---|---|
| Mar2026 | ₹117 Cr |
| Mar2025 | ₹125 Cr |
| Mar2024 | ₹111 Cr |
| Mar2023 | ₹32 Cr |
| Mar2022 | ₹43 Cr |
How is Short Term Provisions of GLAND PHARMA Trending?
| Years | Short Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹117 Cr | -6.08 | |
| Mar2025 | ₹125 Cr | 12.68 | |
| Mar2024 | ₹111 Cr | 242.21 | |
| Mar2023 | ₹32 Cr | -24.44 | |
| Mar2022 | ₹43 Cr | - | |
Compare Short Term Provisions of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹42,004.1 Cr | 1.4% | 4.8% | 25.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -1.5% | 2.5% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹221,666.0 Cr | 7.4% | 22.2% | 26.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,108.0 Cr | 3.1% | 4.3% | 38.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.6% | -1.4% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,990.9 Cr | 1.5% | -15.2% | -9.1% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 1.4% |
4.8% |
25.6% |
| SENSEX | 1.2% |
0.4% |
-2.9% |
You may also like the below Video Courses